Adacel launch
Executive Summary
Sanofi-Aventis vaccine Adacel launches in the U.S. for booster immunization against tetanus, diphtheria and acellular pertussis in individuals aged 11-64, the company reports July 25. List price for Adacel is $33.50 per dose; vaccine is provided in packages containing 10-single dose vials. The Tdap vaccine cleared FDA June 10 with a postmarketing commitment for a 16,000-patient epidemiological safety surveillance study (1"The Pink Sheet," June 20, 2005, p. 20)...
You may also be interested in...
Sanofi’s Adacel Tdap Vaccine Receives Broader Approval Than GSK’s Boostrix
Sanofi-Aventis' postmarketing commitments for Adacel include a 16,000-patient epidemiologic safety surveillance study of the tetanus, diphtheria and acellular pertussis vaccine
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.